Objectives: The aim of this double-blind Randomized Controlled Trial study is evaluation of the effect of Cornus mas extract on lipids and blood glucose profiles and leptin in postmenopausal women. Study population and sample size: 84 menopause women (45 to 60 years old) referred to Rassol Akram hospital in Tehran. Inclusion and exclusion criteria: women with menopause who have experienced at least one year after amenorrhea history. They shouldn't: have history of malignancies, have active hepatic or renal disease, take HRT or take progesterone, intake of medicines which have effect on blood sugar or blood lipids and consumption of cornus mas. Samples will be divided into two groups to take 3 capsules containing 300mg Cornus mas extract or placebo starch powder for 8 weeks. Randomization will be done using a software through a computer. At the start of intervention, questionnaires of 24-hour Dietary Recall, physical activity (IPAQ), and general information will be filled out; height and weight will be measured, too. Afterwards 10cc venous blood sample will be taken to measure FBS, Serum Insulin, lipid profiles including Total cholesterol, HDL-chol,LDL-chol, TG and also ApoA1, Apob100, Leptin level, and Fibrinogen level. At the end of the intervention blood sample will be taken again and aforementioned tests will be repeated again.